TY  - GEN
AU  - Tanaka,C
AU  - Yin,O Q P
AU  - Sethuraman,V
AU  - Smith,T
AU  - Wang,X
AU  - Grouss,K
AU  - Kantarjian,H
AU  - Giles,F
AU  - Ottmann,O G
AU  - Galitz,L
AU  - Schran,H
TI  - Clinical pharmacokinetics of the BCR-ABL tyrosine kinase inhibitor nilotinib
SN  - 1532-6535
PY  - 2010///0218
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Area Under Curve
KW  - Dietary Fats
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Food-Drug Interactions
KW  - Fusion Proteins, bcr-abl
KW  - Humans
KW  - Leukocyte Count
KW  - Male
KW  - Middle Aged
KW  - Protein-Tyrosine Kinases
KW  - Pyrimidines
KW  - Solubility
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1038/clpt.2009.208
ER  -